Hover a dot or row, or tab through the dots · bars scaled to the largest round ($142M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-491244
First filed2023-09-01
Latest2023-09-01
Sought$107M
Sold$66.2M
Investors14
Exemptions506(b)
021-419288
First filed2021-10-29
Latest2021-10-29
Sought$150M
Sold$142M
Investors9
Exemptions506(b)
021-375181
First filed2020-09-10
Latest2020-09-10
Sought$76M
Sold$75.5M
Investors10
Exemptions506(b)
021-355731
First filed2019-12-17
Latest2019-12-17
Sought$25.7M
Sold$23.3M
Investors6
Exemptions506(b)
Who backs Truepill, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-09-01
Related persons
Name
Relationship
Paul Greenall
RelationshipExecutive Officer, Director
Daniel Simkin
RelationshipExecutive Officer
Annie Lamont
RelationshipDirector
Larry Renfro
RelationshipDirector
Facts
As its latest Form D states them
Industry
Other Health Care
State
California (CA)
Exemptions
Rule 506(b)
First filed
2019-12-17
Latest filing
2023-09-01
Who backs Truepill, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)